KPC Presence in Pseudomonas aeruginosa Has Minimal Impact on the In Vivo Efficacy of Carbapenem Therapy

類似資料

• In Vivo Efficacy of 1- and 2-Gram Human Simulated Prolonged Infusions of Doripenem against Pseudomonas aeruginosa
  著者:: Crandon, Jared L., 等
  出版事項: (2009)
• In Vivo Efficacy of Human Simulated Regimens of Carbapenems and Comparator Agents against NDM-1-Producing Enterobacteriaceae
  著者:: Wiskirchen, Dora E., 等
  出版事項: (2014)
• Efficacies of Ceftazidime-Avibactam and Ceftazidime against Pseudomonas aeruginosa in a Murine Lung Infection Model
  著者:: Housman, Seth T., 等
  出版事項: (2014)
• Comparative In Vivo Efficacies of Epithelial Lining Fluid Exposures of Tedizolid, Linezolid, and Vancomycin for Methicillin-Resistant Staphylococcus aureus in a Mouse Pneumonia Model
  著者:: Tessier, Pamela R., 等
  出版事項: (2012)
• Efficacy of Humanized Carbapenem and Ceftazidime Regimens against Enterobacteriaceae Producing OXA-48 Carbapenemase in a Murine Infection Model
  著者:: Wiskirchen, Dora E., 等
  出版事項: (2014)